S K Ramamoorthy, M Marangolo, E Durrant, S Akima, D J Gottlieb. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » Antibodies, Monoclonal/adverse effectsAntibodies, Monoclonal, Murine-DerivedAntineoplastic Agents/adverse effectsBone Marrow/drug effectsBone Marrow/pathologyBone Marrow Cells/metabolismHemolysis/drug effectsHemolysis/immunologyHumansLymphoma, Non-Hodgkin/drug therapyMaleMiddle AgedRenal Insufficiency/chemically inducedRhabdomyolysis/chemically inducedRituximabTreatment OutcomeVascular Diseases/chemically induced
Substances： See more » Antibodies, MonoclonalAntibodies, Monoclonal, Murine-DerivedAntineoplastic AgentsRituximab
Year: 2006 PMID： 16690535 DOI： 10.1080/10428190500399193
Source DB: PubMed Journal: Leuk Lymphoma ISSN： 1026-8022